diabetes mellitus, type 2

Showing 1 - 25 of 2,627

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial in Riyadh (interactive Mhealth Lifestyle behavior intervention, Sham)

Recruiting
  • Diabetes Mellitus, Type 2
  • interactive Mhealth Lifestyle behavior intervention
  • Sham
  • Riyadh, Saudi Arabia
    Princess Nourah bint Abdulrahman University
Nov 18, 2022

Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate

Active, not recruiting
  • Neuropathic Pain
  • Diabetes Mellitus, Type 2
  • pregabalin sustained release tablet
  • pregabalin immediate release capsule
  • Cheongju, Chungcheongbuk-do, Korea, Republic of
  • +7 more
Nov 14, 2022

Diabetes, Type 2, Cardiac Surgery Trial in Beijing (Dapagliflozin)

Recruiting
  • Diabetes Mellitus, Type 2
  • Cardiac Surgery
  • Beijing, Beijing, China
    National Clinical Research Center for Cardiovascular Diseases, S
Nov 10, 2022

Triglyceride-Glucose Index in Diabetic Nephropathy in Type

Not yet recruiting
  • Diabetes Mellitus, Type 2
    • (no location specified)
    Oct 28, 2022

    Diabetes, Type 2 Trial in Kuching (Sago starch drink, Corn starch drink)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Sago starch drink
    • Corn starch drink
    • Kuching, Sarawak, Malaysia
    • +3 more
    Oct 26, 2022

    Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Antwerp, Montpellier, Ljubljana (The SHINE SYSTEM)

    Recruiting
    • Diabetes Mellitus
    • +5 more
    • The SHINE SYSTEM
    • Antwerp, Belgium
    • +2 more
    Oct 24, 2022

    Diabetes, Type 2 Trial in Porto Alegre (Operative group of nutrition education)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Operative group of nutrition education
    • Porto Alegre, Rio Grande Do Sul, Brazil
    • +1 more
    Oct 24, 2022

    Diabetes, Type 2 Trial in Chengdu (LY3209590, Insulin Glargine)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 25, 2022

    Diabetes, Type 2, Obesity Trial in San Diego (Mobile health application)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Obesity
    • Mobile health application
    • San Diego, California
      San Diego State University
    Oct 18, 2022

    Diabetes, Type 2 Trial in Worcester (Diabetes BOOST, Usual Care)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Diabetes BOOST
    • Usual Care
    • Worcester, Massachusetts
      University of Massachusetts Medical School
    Oct 19, 2022

    Diabetes, Type 2 Trial in Chapel Hill (Best Practice Advisory, Peer Support)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Best Practice Advisory
    • Peer Support
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Oct 18, 2022

    Bone Turnover in Type 2 Diabetes and Non-diabetes Controls

    Enrolling by invitation
    • Diabetes Mellitus, Type 2
    • Bone Fragile
    • None - crossectional
    • Aarhus N, Denmark
      Aarhus University Hospital
    Oct 14, 2022

    Diabetes, Type 2, Pre Diabetes Trial in Bragança (Olive Leaf Tea, Lifestyle behavior change program (LBC), Placebo tea)

    Enrolling by invitation
    • Diabetes Mellitus, Type 2
    • Pre Diabetes
    • Olive Leaf Tea
    • +2 more
    • Bragança, Portugal
      Instituto Politécnico de Bragança
    Oct 17, 2022

    Essential Hypertension, Diabetes, Type 2 Trial in Seongnam (ATB-1011, ATB-1012, ATB-1013)

    Recruiting
    • Essential Hypertension
    • Diabetes Mellitus, Type 2
    • Seongnam, Gyeonggi, Korea, Republic of
      Seoul National University Bundang Hospital
    Oct 14, 2022

    Diabetes, Type 2 Trial in San Diego (Project Dulce + Dulce Digital)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Project Dulce + Dulce Digital
    • San Diego, California
      Scripps Whittier Diabetes Institute
    Oct 12, 2022

    Replication of SEPRA Diabetes Trial in Healthcare Claims Data

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • New use of semaglutide injection
    • New initiation of "standard of care" (SGL2i, 2nd generation SU, DPP-4i and GLP-1 RA except for semaglutide inj or oral)
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Oct 10, 2022

    Diabetes, Type 2, Overweight Trial in Toronto (Sleeve Gastrectomy AND Pancreas after Kidney Transplantation (Staggered

    Enrolling by invitation
    • Diabetes Mellitus, Type 2
    • Overweight
    • Sleeve Gastrectomy AND Pancreas after Kidney Transplantation (Staggered Approach)
    • Combined Sleeve Gastrectomy and Pancreas transplantation
    • Toronto, Ontario, Canada
      Toronto General Hospital
    Oct 7, 2022

    Periodontitis, Diabetes, Type 2, Cardiovascular Diseases Trial (Periodontal treatment)

    Not yet recruiting
    • Periodontitis
    • +3 more
    • Periodontal treatment
    • (no location specified)
    Oct 5, 2022

    Diabetes, Type 2, PreDiabetes Trial in Cincinnati (iCan Diabetes Self-management and Prevention Support Group)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • PreDiabetes
    • iCan Diabetes Self-management and Prevention Support Group
    • Cincinnati, Ohio
      University of Cincinnati
    Oct 5, 2022

    Subjects With T2D or at Risk of T2D Cohort Follow-up

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • OGTT
    • +2 more
    • Évry, France
      Centre d'Etudes et de Recherche pour l'Intensification du Traite
    Sep 30, 2022

    Diabetes Footcare Companion App for Patients and Carers

    Not yet recruiting
    • Diabetes Mellitus Foot Ulcer
    • +5 more
    • Conversational Agent/Chatbot App
    • Singapore, Singapore
    • +1 more
    Sep 29, 2022

    Diabetes, Type 2, Overweight or Obesity Trial in Ningbo (lifestyle intervention)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Overweight or Obesity
    • lifestyle intervention
    • Ningbo, Zhejiang, China
      Ningbo First Hospital
    Sep 27, 2022

    Diabetes, Type 2, Diabetic Cardiomyopathies Trial in Cairo (Trimetazidine DiHCl, Placebo)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Diabetic Cardiomyopathies
    • Trimetazidine Dihydrochloride
    • Placebo
    • Cairo, Egypt
      Ainshams university hospitals
    Sep 26, 2022

    Bioequivalence, Diabetes, Type 2 Trial in Mount Royal (Sitagliptin/Metformin HCl 50/850 mg film-coated tablet)

    Completed
    • Bioequivalence
    • Diabetes Mellitus, Type 2
    • Sitagliptin/Metformin HCl 50/850 mg film-coated tablet
    • Mount Royal, Quebec, Canada
      Algorithme Pharma
    Sep 20, 2022

    Diabetes, Type 2 Trial in Erzurum (Motivational Interviewing)

    Completed
    • Diabetes Mellitus, Type 2
    • Motivational İnterviewing
    • Erzurum, Turkey
      Erzurum Technical University Faculty
    Sep 15, 2022